跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Latanopta - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Latanopta
Approved
STANDARD
Latanopta
Beximco Pharmaceuticals Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
560056fc7d185dc2
Company
Beximco Pharmaceuticals Ltd
Type
Standard
Approval Details
Approval Id
560056fc7d185dc2
Drug Approval Philippines Name
Latanopta
Product Name
Latanopta
Registration Number
DRP-10280
Brand Name
Latanopta
Generic Name
Latanoprost
Dosage Form
Ophthalmic Solution
Dosage Strength
50 mcg/mL
Manufacturer
Beximco Pharmaceuticals Ltd
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/beximco-pharmaceuticals-ltd-kaliako
Issuance Date
20 March 2024
Expiry Date
10 October 2029
Pharmacologic Category
Prostaglandin Analogue
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
560056fc7d185dc2
Type
Standard
Back to Philippines FDA Approvals